Fig. 7From: Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needsMultivalent antibody nanoparticles. Virus proteins can assemble into virus-like particles also when one of them is fused to antibody fragments. The outcome is represented by multivalent nanostructures exposing active antibodies. The nanostructure high avidity confers elevated neutralizing effectBack to article page